By fusing the dCas9 protein to p300, the dCas9-p300 system can selectively target and activate specific genes in the genome, offering a powerful tool for studying gene regulation and potentially treating genetic diseases (Klann et al., 2017). The gene discussed is EP300; the disease is hereditary disease.